drugset

drugset / Trial / NCT00137748

Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients

NCT00137748 ↗

Phase 2/3 Completed 50 enrolled The Cleveland Clinic

RandomizedSingle-groupOpen-labelPrevention

Summary

This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.

Timeline

Start: 2001-01
Primary completion: 2006-01
Completion: 2006-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cytogam	Protein / enzyme biologic	—	—

Indications